Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13R?2-targeted CAR T-Cells in High-Grade Glioma
Stock Information for Mustang Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.